Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 32 peer-reviewed journal articles Updated
Dermatology · Folliculitis Decalvans

Is Isotretinoin Right for Folliculitis Decalvans Treatment?

At a Glance

Isotretinoin may reduce inflammation and further scarring in folliculitis decalvans, but it will not restore hair lost to scarring. Safe use requires dermatologist supervision, pregnancy prevention when applicable, blood and liver tests, mood review, and prompt attention to serious warning signs.

In this answer

4 sections

01

When Isotretinoin is Considered and What to Expect

02

Common Side Effects

03

Severe Side Effects: When to Seek Urgent Help

04

Important Monitoring and Safety Requirements

Isotretinoin is an oral medication that may be used off-label to treat Quinquaud folliculitis decalvans—a rare, inflammatory disease that damages hair follicles and causes permanent, scarring hair loss. The goal of treatment is to control active inflammation and reduce the risk of further scarring, though it will not regrow hair in areas where scarring has already caused permanent loss [1]. Because it is a powerful medication with significant safety requirements and potential side effects, it requires careful, ongoing monitoring and strict pregnancy prevention measures [2][3].

When Isotretinoin is Considered and What to Expect

The evidence for using isotretinoin in folliculitis decalvans comes mostly from small observational studies rather than large clinical trials [4]. Dermatologists may consider it based on expert guidelines for specific situations:

  • When it is used: It may be recommended for persistent disease that is not responding to usual treatments (refractory disease), or when patients experience rapid relapse after stopping oral antibiotics [1][4]. Expert guidelines also suggest it for mild inflammatory disease without pustules or crusts [1]. However, this does not mean patients with pustules cannot be treated; your dermatologist will weigh your disease activity, previous treatments, and personal risks to determine if it is appropriate for you.
  • Slower onset and potential for remission: Improvement is not immediate, and a typical treatment course may last several months [5]. Some small studies suggest that a portion of patients can achieve inactive disease (remission) and remain relapse-free for months or up to two years after stopping [6][5]. However, this is not a guaranteed cure, and relapse is still possible.

Common Side Effects

Isotretinoin frequently causes side effects that are often dependent on the dose [7]. These are generally manageable with early, proactive care:

  • Skin and lip dryness: Dry lips and dry skin (xerosis) are very common [7]. Starting a daily routine of lip balms and skin moisturizers as soon as you begin treatment is highly recommended [8].
  • Nasal issues: The inside of the nose can become dry and crusty, increasing the likelihood of nosebleeds (epistaxis) [9]. Using nasal moisturizers (like saline gel) can help reduce this risk [10].
  • Sun sensitivity: The medication makes your skin more sensitive to the sun, so strict sun protection is essential [10].
  • Eye and joint symptoms: Dry eyes are common. You may need clinician-approved lubricating eye drops and might find contact lenses uncomfortable [11][12]. Musculoskeletal symptoms, such as back or joint pain, are also frequently reported [13].

Severe Side Effects: When to Seek Urgent Help

While common side effects are manageable, some rare reactions require immediate medical evaluation [14]. Guidelines advise patients to stop the medication and contact their doctor or seek emergency care immediately if they experience:

  • Severe or persistent headache, nausea and vomiting, or blurred/double vision, which can be signs of dangerous pressure in the brain [15].
  • New or worsening severe depression, unusual behavior, or suicidal thoughts [16][17].
  • Severe abdominal pain or repeated vomiting [18][19].
  • Yellowing of the skin or eyes or very dark urine [20].
  • Severe skin rash or facial swelling [21].
  • Suspected pregnancy [3].

Important Monitoring and Safety Requirements

Because of its broad impact on the body, dosing and monitoring must follow strict local prescribing rules and be individualized [22][23].

Strict Pregnancy Prevention and Blood Donation

Isotretinoin is strongly teratogenic—it causes severe, life-threatening birth defects and must NEVER be used during pregnancy [24][3]. Breastfeeding is also not recommended while on this medication.

  • Pregnancy prevention programs: People who can become pregnant must enroll in mandatory, locally regulated programs (such as iPLEDGE in the US or similar programs in Europe) [25][26]. While exact rules vary by country, these programs generally require using two simultaneous methods of highly effective contraception (or strict abstinence), taking pregnancy tests before, during, and after treatment, and avoiding pregnancy for at least one month after the final dose [3][22].
  • Blood donation: Because of the severe risk to a developing fetus, you are restricted from donating blood while taking isotretinoin and for a period after your last dose—typically at least one month, as required by your local product label or program [2][26].

Lab Tests and Mental Health Review

  • Lipid and liver monitoring: Isotretinoin can elevate liver enzymes and blood fats (lipids, such as triglycerides) [27]. A typical timeline involves checking these blood levels before starting and again within the first month or two [28][29]. Further testing frequency will depend on your baseline results and local guidelines.
  • Mental health review: The relationship between isotretinoin and psychiatric symptoms is complex and uncertain [16]. A history of depression does not automatically prevent you from taking it, but you must discuss your baseline mood history with your doctor. Promptly report any new or worsening depression, anxiety, or marked mood changes [17].

Drug Interactions

Always have your prescriber or pharmacist review all your new and current medications, over-the-counter drugs, and supplements.

  • Tetracyclines: Do not take tetracycline antibiotics (like doxycycline or minocycline) while on isotretinoin, as the combination increases the risk of intracranial hypertension (dangerously high pressure in the skull) [30]. Because these antibiotics are often used for folliculitis decalvans, work with your doctor on a safe transition plan—do not abruptly stop or start an antibiotic on your own.
  • Vitamin A: Isotretinoin is a derivative of vitamin A. Taking multivitamins or acne supplements that contain vitamin A can increase the risk of toxicity and must be avoided [31][32].

Common questions in this guide

Why might a dermatologist prescribe isotretinoin for folliculitis decalvans?
A dermatologist may consider isotretinoin, a medicine used outside its approved indication, when folliculitis decalvans remains active despite usual treatment, relapses quickly after oral antibiotics, or causes mild inflammation without pustules or crusts. It is intended to calm active inflammation and limit additional scarring, not to regrow hair already permanently lost.
How long does isotretinoin take to work for folliculitis decalvans?
Improvement is usually gradual, and a course often lasts several months. Small studies suggest some people stay clear for months or up to two years after treatment, but relapse remains possible and results are not guaranteed.
What side effects are common with isotretinoin?
Dry lips and skin are very common. Nasal dryness or nosebleeds, increased sun sensitivity, dry eyes, discomfort with contact lenses, and back or joint pain can also occur.
Which isotretinoin symptoms require urgent medical help?
Stop isotretinoin and contact your doctor urgently or seek emergency care for a severe or persistent headache with nausea, vomiting, or blurred or double vision; new severe depression, unusual behavior, or suicidal thoughts; severe abdominal pain; yellow skin or eyes; dark urine; a severe rash or facial swelling; or a suspected pregnancy. These symptoms can signal serious complications and should not be managed without medical advice.
What monitoring is needed during isotretinoin treatment?
Before and during treatment, your clinician may check blood fats and liver enzymes, review your mood and medical history, and adjust testing based on your results and local rules. People who can become pregnant generally need enrollment in a local safety program, highly effective contraception or strict abstinence, and pregnancy tests before, during, and after treatment. Pregnancy must be avoided during treatment and for at least one month after the last dose.
Can I take doxycycline, minocycline, or vitamin A with isotretinoin?
Do not take tetracycline antibiotics such as doxycycline or minocycline with isotretinoin unless your prescriber gives you a safe plan, because the combination can dangerously raise pressure inside the skull. Avoid vitamin A supplements and ask a pharmacist or prescriber to review all medicines, multivitamins, and supplements.

Related questions

Can Folliculitis Decalvans Affect Facial or Body Hair? Can Folliculitis Decalvans Scars Turn Into Skin Cancer? Do Topical Treatments Help Folliculitis Decalvans Flares? How Common Is Folliculitis Decalvans and Who Gets It? How Do Doctors Assess Folliculitis Decalvans Activity?
Show more
How Is Folliculitis Decalvans Diagnosed vs LPP and AKN? How Long Does Folliculitis Decalvans Treatment Take to Work? How Often Do I Need Quinquaud FD Follow-Up Visits? Is Quinquaud Folliculitis Decalvans Contagious to Others? Is Folliculitis Decalvans Treatment Safe in Pregnancy? Should I Send Scalp Biopsy Slides or a Tissue Block? What Are the Risks of Long-Term Antibiotics for FD? What Causes Quinquaud Folliculitis Decalvans? Beyond Hygiene What Is FD-LPP Overlap Syndrome? Meaning and Signs What Is the Prognosis and Course of Folliculitis Decalvans? Folliculitis Decalvans Scalp Biopsy: What to Expect Folliculitis Decalvans: When to Repeat Biopsy or Culture? Why Does Folliculitis Decalvans Relapse After Antibiotics? Why Is a Scalp Culture Done for Folliculitis Decalvans?

Get notified when new evidence is published on Quinquaud folliculitis decalvans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (32)
  1. 1

    Management of folliculitis decalvans: The EADV task force on hair diseases position statement.

    Waśkiel-Burnat A, Starace M, Iorizzo M, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.

    PMID: 40230058
  2. 2

    Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin.

    Dessinioti C, Zouboulis CC, Bettoli V, Rigopoulos D

    Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(10)):2229-2240 doi:10.1111/jdv.16430.

    PMID: 32277497
  3. 3

    Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi-stakeholder cross-sectional study.

    Hughes JE, Buckley N, Looney Y, et al.

    Pharmacoepidemiology and drug safety 2023; (32(2)):137-147 doi:10.1002/pds.5538.

    PMID: 36073295
  4. 4

    Navigating Treatments in Folliculitis Decalvans: A Comprehensive Systematic Review.

    Al-Naesan I, Trafoier T, Krepper D, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2026; doi:10.1111/ddg.70607.

    PMID: 42750403
  5. 5

    Isotretinoin treatment for folliculitis decalvans: a retrospective case-series study.

    Aksoy B, Hapa A, Mutlu E

    International journal of dermatology 2018; (57(2)):250-253 doi:10.1111/ijd.13874.

    PMID: 29313960
  6. 6

    Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients.

    Tietze JK, Heppt MV, von Preußen A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1816-21 doi:10.1111/jdv.13052.

    PMID: 25712452
  7. 7

    Adverse effects of isotretinoin: A large, retrospective review.

    Brzezinski P, Borowska K, Chiriac A, Smigielski J

    Dermatologic therapy 2017; (30(4)) doi:10.1111/dth.12483.

    PMID: 28295859
  8. 8

    Isotretinoin for acne vulgaris - an update on adverse effects and laboratory monitoring.

    Fallah H, Rademaker M

    The Journal of dermatological treatment 2022; (33(5)):2414-2424 doi:10.1080/09546634.2021.1967269.

    PMID: 34379039
  9. 9

    Isotretinoin-induced epistaxis among acne vulgaris patients: A cross sectional study from Saudi Arabia.

    Almuzaini HI, Alamri AS, Almuzaini RI

    Saudi medical journal 2024; (45(12)):1347-1354 doi:10.15537/smj.2024.45.12.20240791.

    PMID: 39658113
  10. 10

    A Common Drug With a Dangerous Side Effect: Acute Rhabdomyolysis Caused by the Synergistic Effect of Isotretinoin and Exercise in an Adolescent.

    Dasgupta K, Lim P, Reedstorm H

    Cureus 2020; (12(10)):e10929 doi:10.7759/cureus.10929.

    PMID: 33194495
  11. 11

    Ocular side effects of systemic isotretinoin - a systematic review and summary of case reports.

    Lamberg O, Strome A, Jones F, et al.

    The Journal of dermatological treatment 2023; (34(1)):2213364 doi:10.1080/09546634.2023.2213364.

    PMID: 37248700
  12. 12

    Isotretinoin and Dry Eye Disease: A Systematic Review.

    Fineide FA, Reppe S, Mantaka P, et al.

    Current eye research 2026; 1-9 doi:10.1080/02713683.2026.2713384.

    PMID: 42554012
  13. 13

    Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study.

    Acar EM, Şaş S, Koçak FA

    Archives of rheumatology 2022; (37(2)):223-229 doi:10.46497/ArchRheumatol.2022.8645.

    PMID: 36017204
  14. 14

    Routine blood monitoring in acne vulgaris patients on isotretinoin: Is reassessment warranted? A retrospective cohort study from Tygerberg Hospital.

    Du Toit J, Gray NA, Esterhuizen TM, Visser WI

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2026; (116(4)):e3588 doi:10.7196/SAMJ.2026.v116i4.3588.

    PMID: 42246839
  15. 15

    Highlighting Ophthalmic Adverse Effects Associated with Isotretinoin.

    Pan JT, Daniel BS, Tan B, et al.

    Life (Basel, Switzerland) 2026; (16(9)) doi:10.3390/life16091441.

    PMID: 42795306
  16. 16

    Real-World Evidence of Neuropsychiatric Adverse Reactions to Isotretinoin: Insights from EudraVigilance (2005-2025).

    Szilagyi DV, Tit DM, Judea-Pusta CT, et al.

    Pharmaceuticals (Basel, Switzerland) 2025; (18(9)) doi:10.3390/ph18091252.

    PMID: 41011124
  17. 17

    Mood changes and clinical decision making in adolescent patients on isotretinoin therapy for acne vulgaris.

    Gradwohl K, Verghese M, Rosenblatt AE

    Pediatric dermatology 2023; (40(3)):494-496 doi:10.1111/pde.15324.

    PMID: 37037198
  18. 18

    Isotretinoin induced small vessel vasculitis: a life-threatening pulmonary-renal syndrome-a case report.

    Annangi S, Pasha S

    Annals of translational medicine 2021; (9(7)):584 doi:10.21037/atm-20-4212.

    PMID: 33987282
  19. 19

    [Alitretinoin (Toctino®): A French follow-up study of harmacovigilance].

    Vrignaud L, Simon C, Agier MS, et al.

    Therapie 2019; (74(5)):513-519 doi:10.1016/j.therap.2019.02.006.

    PMID: 31014976
  20. 20

    Myositis Induced by Isotretinoin: A Case Report and Literature Review.

    Rivillas JA, Santos Andrade VA, Hormaza-Jaramillo AA

    The American journal of case reports 2020; (21()):e917801 doi:10.12659/AJCR.917801.

    PMID: 31958335
  21. 21

    Efficacy and adverse events of oral isotretinoin for acne: a systematic review.

    Vallerand IA, Lewinson RT, Farris MS, et al.

    The British journal of dermatology 2018; (178(1)):76-85 doi:10.1111/bjd.15668.

    PMID: 28542914
  22. 22

    Compliance with the pregnancy prevention program among women initiating isotretinoin treatment between 2014 and 2021: A nationwide cohort study on the French Health Data System (SNDS).

    Havet A, Bouvard C, Moskal A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(4)):806-814 doi:10.1111/jdv.20073.

    PMID: 38764351
  23. 23

    Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis.

    Durán CE, Riera-Arnau J, Abtahi S, et al.

    Frontiers in pharmacology 2023; (14()):1207976 doi:10.3389/fphar.2023.1207976.

    PMID: 37663263
  24. 24

    Awareness of isotretinoin use and Saudi FDA pregnancy prevention program in Riyadh, Saudi Arabia: A cross-sectional study among female patients.

    Ibrahim AAM, Alshatri AA, Alsuwaidan S, et al.

    Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2021; (29(6)):527-532 doi:10.1016/j.jsps.2021.04.013.

    PMID: 34194259
  25. 25

    Simplifying contraception requirements for iPLEDGE: A decision analysis.

    Barbieri JS, Roe AH, Mostaghimi A

    Journal of the American Academy of Dermatology 2020; (83(1)):104-108 doi:10.1016/j.jaad.2020.02.022.

    PMID: 32068040
  26. 26

    A comparative review of the isotretinoin pregnancy risk management programs across four continents.

    Kovitwanichkanont T, Driscoll T

    International journal of dermatology 2018; (57(9)):1035-1046 doi:10.1111/ijd.13950.

    PMID: 29508918
  27. 27

    Standardized laboratory monitoring with use of isotretinoin in acne.

    Hansen TJ, Lucking S, Miller JJ, et al.

    Journal of the American Academy of Dermatology 2016; (75(2)):323-8.

    PMID: 27189824
  28. 28

    Risk and timing of isotretinoin-related laboratory disturbances: a population-based study.

    Emtenani S, Abdelghaffar M, Ludwig RJ, et al.

    International journal of dermatology 2024; (63(12)):1740-1747 doi:10.1111/ijd.17225.

    PMID: 38702860
  29. 29

    Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study.

    Xia E, Han J, Faletsky A, et al.

    JAMA dermatology 2022; (158(8)):942-948 doi:10.1001/jamadermatol.2022.2044.

    PMID: 35704293
  30. 30

    Coprescription of Isotretinoin and Tetracyclines for Acne is Rare: An Analysis of the National Ambulatory Medical Care Survey.

    Reserva J, Adams W, Perlman D, et al.

    The Journal of clinical and aesthetic dermatology 2019; (12(10)):45-48.

    PMID: 32038749
  31. 31

    Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.

    Bagatin E, Costa CS, Rocha MADD, et al.

    Anais brasileiros de dermatologia 2020; (95 Suppl 1()):19-38 doi:10.1016/j.abd.2020.09.001.

    PMID: 33036809
  32. 32

    The impact of isotretinoin on the pituitary-ovarian axis: An interpretative review of the literature.

    Abdelhamed A, Ezz El-Dawla R, Karadag AS, et al.

    Reproductive toxicology (Elmsford, N.Y.) 2021; (104()):85-95 doi:10.1016/j.reprotox.2021.06.017.

    PMID: 34224824

This page is for informational purposes only and does not constitute medical advice about isotretinoin for folliculitis decalvans. Your dermatologist should determine whether it is appropriate and arrange individualized monitoring and pregnancy precautions.